KOWA COMPANY, LTD. (E02819)

Market cap
P/E ratio
Kowa develops and sells prescription and over-the-counter medicines including popular nutritional drinks and cold remedies, while also operating trading, optical equipment, and hospitality businesses across 117 global subsidiaries.
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 2023654.2-893.82%
Mar 31, 2022-82.4-262.96%
Mar 31, 202150.6-9.14%
Mar 31, 202055.7-155.32%
Mar 31, 2019-100.6+14.16%
Mar 31, 2018-88.1+112.36%
Mar 31, 2017-41.5-260.48%
Mar 31, 201625.9-105.21%
Mar 31, 2015-496.6-1186.48%
Mar 31, 201445.7-9.54%
Mar 31, 201350.5-85.79%
Mar 31, 2012355.5+160.38%
Mar 31, 2011136.5+84.56%
Mar 31, 201074
AI Chat